Literature DB >> 21396440

Cytotoxicity in L929 fibroblasts and inhibition of herpes simplex virus type 1 Kupka by estuarine cyanobacteria extracts.

Viviana R Lopes1, Michaela Schmidtke, M Helena Fernandes, Rosário Martins, Vitor Vasconcelos.   

Abstract

The cyanobacteria are known to be a rich source of metabolites with a variety of biological activities in different biological systems. In the present work, the bioactivity of aqueous and organic (methanolic and hexane) crude extracts of cyanobacteria isolated from estuarine ecosystems was studied using different bioassays. The assessment of DNA damage on the SOS gene repair region of mutant PQ37 strain of Escherichia coli was performed. Antiviral activity was evaluated against influenza virus, HRV-2, CVB3 and HSV-1 viruses using crystal violet dye uptake on HeLa, MDCK and GMK cell lines. Cytotoxicity evaluation was performed with L929 fibroblasts by MTT assay. Of a total of 18 cyanobacterial isolates studied, only the crude methanolic extract of LEGE 06078 proved to be genotoxic (IF > 1.5) in a dose-dependent manner and other four were putative candidates to induce DNA damage. Furthermore, the crude aqueous extract of LEGE 07085 showed anti- herpes type 1 activity (IC50 = 174.10 μg dry extract mL(-1)) while not presenting any cytotoxic activity against GMK cell lines. Of the 54 cyanobacterial extracts tested, only the crude methanolic and hexane ones showed impair on metabolic activity of L929 fibroblasts after long exposure (48-72 h). The inhibition of HSV-1 and the strong cytotoxicity against L929 cells observed emphasizes the importance of evaluating the impact of those estuarine cyanobacteria on aquatic ecosystem and on human health. The data also point out their potential application in HSV-1 treatment and pharmacological interest.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396440     DOI: 10.1016/j.tiv.2011.03.003

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

1.  Exploring bioactive properties of marine cyanobacteria isolated from the Portuguese coast: high potential as a source of anticancer compounds.

Authors:  Margarida Costa; Mónica Garcia; João Costa-Rodrigues; Maria Sofia Costa; Maria João Ribeiro; Maria Helena Fernandes; Piedade Barros; Aldo Barreiro; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2013-12-31       Impact factor: 5.118

2.  Pholiota nameko Polysaccharides Promotes Cell Proliferation and Migration and Reduces ROS Content in H2O2-Induced L929 Cells.

Authors:  Tzu-Jung Sung; Yu-Ying Wang; Kai-Lun Liu; Chun-Hsu Chou; Ping-Shan Lai; Chang-Wei Hsieh
Journal:  Antioxidants (Basel)       Date:  2020-01-10

3.  Styrylpyrone Derivative (SPD) Extracted from Goniothalamus umbrosus Binds to Dengue Virus Serotype-2 Envelope Protein and Inhibits Early Stage of Virus Replication.

Authors:  Noor Zarina Abd Wahab; Nazlina Ibrahim
Journal:  Molecules       Date:  2022-07-18       Impact factor: 4.927

4.  Cyanobacterial diversity held in microbial biological resource centers as a biotechnological asset: the case study of the newly established LEGE culture collection.

Authors:  Vitor Ramos; João Morais; Raquel Castelo-Branco; Ângela Pinheiro; Joana Martins; Ana Regueiras; Ana L Pereira; Viviana R Lopes; Bárbara Frazão; Dina Gomes; Cristiana Moreira; Maria Sofia Costa; Sébastien Brûle; Silvia Faustino; Rosário Martins; Martin Saker; Joana Osswald; Pedro N Leão; Vitor M Vasconcelos
Journal:  J Appl Phycol       Date:  2018-01-06       Impact factor: 3.215

5.  Inhibitory effect of microalgae and cyanobacteria extracts on influenza virus replication and neuraminidase activity.

Authors:  Thauane Silva; Paulo S Salomon; Lidilhone Hamerski; Juline Walter; Rafael B Menezes; José Edson Siqueira; Aline Santos; Jéssica Aparecida Morais Santos; Natália Ferme; Thaise Guimarães; Giovana O Fistarol; Paulo I Hargreaves; Cristiane Thompson; Fabiano Thompson; Thiago Moreno Souza; Marilda Siqueira; Milene Miranda
Journal:  PeerJ       Date:  2018-10-26       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.